Overexpression of ST6GalNAcV, a ganglioside-specific ?2,6-sialyltransferase, inhibits glioma growth in vivo Aberrant cell-surface glycosylation patterns are present on virtually all tumors and have been linked to tumor progression, metastasis, and invasivity. We have shown that expressing a normally quies cent, glycoprotein-specific a2,6-sialyltransferase (ST6Gal1) gene in gliomas inhibited invasivity in vitro and tumor formation in vivo. To identify other glycogene targets with therapeutic potential, we cre ated a focused 45-mer oligonucleotide microarray platform repre senting all of the cloned human glycotranscriptome and examined the glycogene expression profiles of 10 normal human brain speci mens, 10 malignant gliomas, and 7 human glioma cell lines. Among the many significant changes in glycogene expression observed, of particular interest was the observation that an additional ot2, 6 sialyltransferase, ST6 (ot-/V-acetyl-neuraminyl-2,3-?-galactosyl-1,3) /V-acetylgalactosaminide a2,6-sialyltransferase 5 (ST6GalNAcV), was expressed at very low levels in all glioma and glioma cell lines exam ined compared with normal brain. ST6GalNAcV catalyzes the forma tion of the terminal a2,6-sialic acid linkages on gangliosides. Stable transfection of ST6GalNAcV into U373MG glioma cells produced (/') no change in a2,6-linked sialic acid-containing glycoproteins, (//') in creased expression of GM2a and GM3 gangliosides and decreased expression of G M 1b, Gb3, and Gb4, (//'/) marked inhibition of in vitro invasivity, (/V) modified cellular adhesion to fibronectin and laminin, (v) increased adhesion-mediated protein tyrosine phosphorylation of HSPA8, and {vi) inhibition of tumor growth in vivo. These results strongly suggest that modulation of the synthesis of specific glioma cell-surface glycosphingolipids alters invasivity in a manner that may have significant therapeutic potential.
glycosyltransferase | glycosphingolipid | glioblastoma | heat shock 70 kDa protein 8 | glycosynapse Aberrations in cell-surface glycosylation patterns are a dis tinguishing feature of all vertebrate tumor cells, including brain tumors (1) . Cell-surface glycoproteins have been identified that are associated with the invasive potential of malignant gliomas (2) . The overexpression of the glycosyltransferase, GnT-V in gli omas, led to increased invasivity of these tumor cells in vitro, suggesting that ?l,6-N-acetylglucosamine-bearing N-glycans play a role in glioma invasivity (3), consistent with earlier reports showing a strong correlation between metastatic potential and the expression of tri-and tetra-antennary ? 1,6NAG-bearing N-glycans (4). And recently, direct demonstration of a role for the Oligo saccharide component of the glioma-associated integrin, a3?l, in regulating glioma invasivity has been reported (5, 6) .
Gangliosides are sialic acid-bearing glycosphingolipids that are an important part of the cell surface glycoconjugates expressed on all mammalian cells. They influence tumor growth and pro gression through modulation of adhesion, migration, and an giogenesis, and their expression is markedly altered in a variety of brain tumors and brain tumor model systems. Hamasaki et al. (7) have reported that GTlb ganglioside can be used as a brain metastasis marker. Mennel and Lell (8) also corroborated earlier reports that simpler ganglioside patterns were associated with the malignancy progression, but not the proliferation patterns, of astrocytomas. And a series of reports by Ladisch and coworkers (9, 10) and Nakamura et al. (11) has shown that human neuro blastomas, medulloblastomas, and astrocytomas shed ganglio sides that can be detected in patient serum and cerebrospinal fluid. Li et al. (12) showed that shed ganglioside GD2 was markedly immunosuppressive and, as such, may facilitate tumor formation and progression. We used focused 45-mer oligonucleotide microarrays coupled with quantitative RT-PCR (qRT-PCR) analyses to comprehen sively query the human glyco-transcriptome (13) and found significantly lower levels of ganglioside-selective ot2,6-sialyl transferase, ST6 (a-N-acetyl-neuraminyl-2,3-?-galactosyl-l,3)-./V acetylgalactosaminide a2,6-sialyltransferase 5 (ST?GalNAcV), in malignant glioblastomas (92 primary tumor specimens and 7 human glioma cell lines) relative to normal brain (34 specimens).
GDI a is the terminal structure of a-series gangliosides and is synthesized from GM lb through the transfer of sialic acid to its ?-acetylgalactosamine residue through an oc2,6-linkage with GMlb (x2,6-sialyltransferase ST?GalNAcV, which, in mice, is only active toward GMlb (12) . Significant down-regulation of ST?GalNAcV has been demonstrated in lung squamous cell carcinoma (14) . Its involvement in the inflammatory breast cancer phenotype (15) and in breast cancer m?tastases to the brain (16) has been reported. Alterations in the adhesive prop erties of HeLa cells by modulation of ST?GalNAcV expression has also been demonstrated (17) . Interestingly, there is little to no a2,6-sialytransferase (ST?Gall) activity, the enzyme that sialylates glycoprotein-associated, N-linked Oligosaccharides, in malignant glioblastomas. Moreover, studies have shown that expression of this sialyltransferase in human glioma model sys tems inhibited both tumor growth and invasivity, by altering the signal transduction capability of the oc3?l integrin, because of its altered terminal sialic acid composition, and reflected in changes in focal adhesion kinase activity (5, 6) .
Thus, studies were undertaken to evaluate the role of ST?GalNAcV in glioma invasivity by creating stable trans fectants and evaluating them for alterations in cell-surface Oli gosaccharide expression, invasive potential in vitro, intracellular protein phosphorylation, and tumorigenicity in vivo. ) by use of a detailed, sensitive, semiquantitative method using lipid extraction, one-step nano-liquid chromatography (nLC) separation, and high-resolution mass analysis (18, 19) . We observed significant modulation of specific gangliosides in the a-series pathway (Fig. 2) . As ST?GalNAcV directs the synthesis of GDla in mice, we initially expected that the increased cell surface SNA reactivity was due to specific increases in this rare, brain-specific ganglioside. The lipid profiling data clearly dem onstrate that, despite no change in GDla content in the trans fectants, there was an ?7-fold increase in another a2,6
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sialoganglioside, GM2a, with a concomitant ?3-fold decrease in GMlb and ?2-fold decreases in Gb3 and Gb4. A 2-fold increase in GM3 was also observed in the transfectant clones. Sialic acid linked to GalNAc is thought to be relatively rare in most tissues.
Although GM2a may constitute only a minor ganglioside com ponent, the lack of appropriate standards does not allow mea surement of its absolute concentration. Nonetheless, the 7-fold increase in GM2a containing the dl8:l-C16:0 ceramide structure common in many tumor cells had the highest ion abundance measured across all transfectant samples (Table S2 and Fig. S2 ).
Electron-induced dissociation (EID) experiments, performed on selected ions from the nLC effluent after peak-parking to differentiate between globo-series Gb4 and iso-globoseries iGb4 isomers, confirmed the presence of Gb4 and not iGb4 (Fig. S3 ). EID fragmentation of Gb3/iGb3 was also performed, but be cause of the highly symmetrical nature of the glycan residue, we were unable differentiate between Gb3 and iGb3. Because Gb4 is biosynthesized from Gb3 and not iGb3, Gb3 is the most likely isomer detected.
In Vitro Invasivity. The four clones examined represented a spec trum of ST?GalNAcV overexpression ranging from 2-to 25-fold. The decrease in in vitro invasivity was directly related to the level of expression of ST?GalNAc mRNA, with clones S8 and S25, the highest expressers, displaying ?20% of the invasivity of the control cells (Fig. 3) . Thus, within the limits of quantitation used in these analyses, it appears compelling that the greater the ST?GalNAcV mRNA levels, the greater the quantity of cell surface-expressed a2,6-linked glycolipids and the lesser the in vitro invasivity of the transfectants.
In Vitro Adhesion. One of the primary mechanisms to modulate cellular invasivity is via differential adhesion to extracellular ma trix (ECM). adhesion to laminin was observed in the two clones (S8 and S25) demonstrating comparatively high levels of ST?GalNAcV mRNA expression and cell surface a2,6-linked gangliosides (Fig. 4) . No significant difference in adhesion to collagen was demonstrated.
Adhesion-Mediated Protein Tyrosine Phosphorylation. Altered ad hesivity of U373MG cells to fibronectin by modulation of cell surface N-linked glycoconjugates is mediated by altered tyrosine phosphorylation of pl25F (5) . Regulation of laminin-mediated signaling in other systems has also been described (20) . After adhesion to laminin, both the qualitative and quantitative pattern of phosphorylated proteins in each of the clones was identical to that observed in control cells (Fig. S4) . After adhesion to fibro nectin, however, there was a striking difference in the level of phosphorylation of a 75-kDa protein in all of the transfectants. The abundance of this 75-kDa phosphoprotein directly correlated with the level of ST?GalNAcV expression (Fig. 5A) . The identity of this 75-kDa phosphoprotein (pp75) and the signaling pathway altered by aberrant glycolipid expression in these transfectants was examined.
Identification of pp75. After Off-Gel Electrophoretic (OGE) and antiphosphotyrosine Western blot analyses, pp75 was identified in the fraction corresponding to an approximate pi range of antibodies followed by antiphosphotyrosine Western blot analy sis demonstrated a significant increase in HSPA8 phosphoryla tion after adhesion to fibronectin (Fig. 5C ). No change in Keapl phosphorylation was observed (Fig. S5 ).
Intracranial Tumorigenicity. Intracranial tumor growth by ST6Gal
NAcV-transfected U373MG (clones S8 and S25), parental U373MG, and pcDNA3 vector-transfected control cells was examined after stereotactic implantation into SCID mice (Fig. 6 A-C). Both parental and vector-transfected U373MG cells formed large tumors in vivo. Tumors formed by the ST6GalNAcV transfected U373MG clones were, on average, 20-25% the size of those formed by vector-transfected U373MG cells (Fig. 6D ).
Discussion
In this study, we have demonstrated that ST6GalNAcV over expression in tumorigenic, human U373MG glioma cells leads to (/) increased expression of GM2oc and GM3 gangliosides, and de creased expression of GM lb, Gb3, and Gb4, (//) no change in De linked sialic acid-containing glycoproteins, (///) marked inhibition of in vitro invasivity with no effect on cellular proliferation, (iv) modified cellular adhesion to fibronectin leading to significantly increased adhesion-mediated protein tyrosine phosphorylation of HSPA8 that directly correlated with decreased in vitro invasivity, and (vi) significant inhibition of in vivo tumor growth. These results strongly suggest that modulation of the synthesis of specific glioma cell-surface glycosphingolipids alters adhesion and invasivity in a manner that may play a significant role in gliomagenesis.
In mice, ST6GalNAcV encodes an enzyme catalyzing the for mation of GDI a, a relatively minor brain-specific ganglioside in the "0" biosynthetic pathway (21) . The lack of GDloc and the elevated expression of GM2a in the U373MG stable transfectants described here is unexpected and may result from compen satory mechanisms after long-term ST?GalNAcV expression. In humans, the "a" and "b" biosynthetic pathways are far more ac tive than the "0" pathway, which would result in synthesis of GTla from GDla and GQlb from GTlb. Because we did not detect any of these products in our lipidomic analysis, it may be more likely that the synthesis of GM2a results from altered substrate avail ability. Recent studies in GM3-deficient fibroblasts have dem onstrated compensatory shunting of ganglioside biosynthesis toward the normally quiescent "0" pathway in murine cells but not in human cells, with differing alternative glycosphingolipid pathways used to functionally compensate for aberrant ganglio side biosynthesis (21, 22) . The reduced expression of Gb3 and Gb4 observed in the transfectants is also consistent with such potential shunting of ganglioside biosynthetic pathways toward the synthesis of GM2a. At any rate, the stable overexpression of ST?GalNAcV leads to the production of nascent oc2,6-linked sialoglycoconjugates on the cell surface. It also follows that the relatively low, yet significant, cell surface SNA reactivity observed in the clones exhibiting the highest levels of ST?GalNAcV expression is likely due to the low affinity of this lectin for sialic acid that is a2,6-linked to 7V-acetylgalactosamine, as opposed to galactose.
The modest increase in GM3 synthesis, a ganglioside pos sessing modulatory effects on glioma growth, adhesion, and invasivity (23), is also intriguing. At high concentrations, GM3 inhibits glioma cell proliferation predominantly by inhibition of tyrosine phosphorylation of EGF, PDGF, or FGF receptors. In our studies, no changes in cellular proliferation or in tyrosine phosphorylation of these receptors in the transfectant clones were observed. High concentrations of GM3 also inhibit tumor cell invasion predominantly via interference with integrin re ceptor function, which would also be reflected in events down stream of the receptor. The predominant integrin in U373MG cells is a3?l, whose primary downstream effect is tyrosine phosphorylation of pl25FAK (5). We also did not observe ad hesion-mediated alterations in pl25FAK expression in the trans fectants. We interpret these observations to suggest that the 2 fold increase in GM3 content in the transfectants was not suffi cient to explain the differences in in vitro invasivity or inhibition of in vivo tumor growth that we have demonstrated.
In addition to their well studied roles as epitopes/cell surface markers, gangliosides participate in multiple biological functions, including inter-and intracellular signaling functions (24) . Aber rantly expressed cell surface gangliosides have been demon strated to directly impact intracellular signaling. Alteration of glycosylation in glycolipids affects intracellular localization of integrin, src, and caveolin into or out of glycolipid-enriched microdomains (25) . The association of GD2 with the integrin/ FAK macromolecular complex has also been demonstrated (26) . GD3-mediated inhibition of laminin 5-dependent cell motility is due to disruption of specific interactions between CD9 and oc3 integrin in GD3-containing microdomains (27) . Ganglioside alterations in epithelial cells leading to changes in (/) adhesion to specific extracellular matrix components, (ii) relative rates of cellular proliferation and apoptosis, (///) protease activation and function, and (iv) disruption of cell surface integrimgrowth factor receptor. associations have also been described (28) . Signifi cantly, GTlb-induced apoptosis in SCC12 cells by direct binding to oc5?l leads to decreased activity of the integrin-linked kinase/ protein kinase B/AKT pathway (29) . Although the detailed molecular mechanisms of specific glycosphingolipid modulation on glioma invasivity may differ, it is nonetheless clear that ab errant signal transduction plays a pivotal role.
The opposing effects of ST?GalNAcV overexpression on ad hesion to laminin vs. fibronectin are seemingly paradoxical. Up regulated expression of ST?GalNAcV may result in signal transduction cascades that culminate in different membrane protein expression profiles that, on one hand, are favorable to adhesion to laminin, and on the other hand, not favorable to adhesion to fibronectin. In support of this hypothesis, we did not measure any significant changes in signal transduction (measured at the level of laminin-mediated tyrosine phosphorylation) in the transfectants. Another possibility is that the effects on the receptors responsible for adhesion to different substrates may be differentially susceptible to glycolipid-associated alterations in membrane microdomains in the transfectants. Altered glioma cell adhesion to laminin has been demonstrated not to be suffi cient to affect invasion (30) .
Unlike the effects of adhesion to fibronectin on protein tyrosine phosphorylation in glioma cells expressing the glycoprotein ST?Gall (5) , no decrease in pl25F phosphorylation was ob served in these studies. There was, however, a direct relationship between the level of overexpression of ST?GalNAcV and the level of protein tyrosine phosphorylation of a unique 75-kDa (p75) protein after adhesion to fibronectin. Detailed phosphoproteomic analysis demonstrated that overexpression of ST?GalNAcV leads to enhanced de novo phosphorylation of HSPA8/HSC70 in re sponse to attachment to fibronectin. We hypothesize that this phosphorylation is caused by the expression of GM2oc ganglioside synthesized by this enzyme and plays a key role in regulating al tered adhesivity. It seems reasonable to generalize that these data imply that ganglioside signal transduction is an important part of the mechanisms that underlie glioma invasivity.
Further supporting this hypothesis, it has been reported that HSPA8 is colocalized with cytoskeletal-associated proteins in the extended pseudopodial protrusions of highly invasive variants of canine kidney tumor cells (31) . There is increasing evidence that phosphorylation of cell-surface-expressed heat shock proteins (HSPs) are intimately involved in tumor cell adhesion, motility, and invasion (32, 33) . The effect of specific tyrosine phosphory lation of HSPA8 in mitotic and tumor cells (34) on cellular lo calization and function (35) has been demonstrated. In human D54MG glioma cells, siRNA-mediated knockdown of HSPA8 expression is associated with decreased glioma cell migration through vitronectin-coated membranes (36) . Alteration in HSPA8 phosphorylation has been demonstrated in integrin-mediated platelet adhesion to collagen (37) . The authors proposed that heat shock proteins, including HSPA8, act as signaling scaffolds regu lating platelet adhesion and spreading (38) . HSPA8 is coexpressed with, and anchored by, cytoskeletal ?-actin on the cell surface of HTLV-susceptible cells and is an integral part of a complex supported by palmitoyl (16:0)-oleoyl (18:l)-phosphatidylglycerol in the lipid bilayer (39) . The N-terminal ATPase-containing do main of HSPA8 involved in uncoating of clathrin-coated vesicles has been shown to directly bind to cell surface 3'-sulfogalactoli pids, sulfogalactosyl ceramide, and sulfogalactoglycerolipid (40) . Because membrane localization of HSPs appears to be restricted to lipid rafts/glycosynapses on transformed cells (41) and is spe cifically associated with Gb3 in colon and pancreatic tumor cells (42) , perhaps the differential phospho-HSPA8-mediated signal transduction modulated by specific membrane ganglioside content provides the scaffold for signal transduction cascades in glial tumors.
Hakomori (43, 44) has discussed models of how altered mem brane glycosphingolipids (GSL) can influence the tumorigenic phenotype, based on their ability to form clusters at the cell surface and interact with various functional components on the cell membrane. These clusters (or "glycosynapses") interact with such functional membrane proteins, including integrins, growth factor receptors, tetraspanins, and nonreceptor cytoplasmic protein kinases (e.g., src kinases and small G proteins) that ultimately control GSL-modulated cell adhesion, growth, and motility. It is through this framework that modulation of cell surface carbohy drate expression and subsequent disorganization of cell mem brane components can mediate cell signaling, leading to changes in cellular phenotype.
From the "glycosynapse" perspective, our results can be sum marized in the following way: Manipulation of the synthesis of cell surface gangliosides by ST?GalNAcV gene transfer alters the composition of specific membrane domains. Alteration in the composition of specific membrane domains, in turn, alters ad hesivity to ECM components, increases the phosphorylation of HSPA8 protein, and decreases the invasive potential and in vivo tumorigenicity of glioma cells. Based on this and previous studies (3, 5, 6) , modulating the expression of cc2,6-sialic acids on either gangliosides or the N-linked Oligosaccharides expressed on cell surface signaling molecules (i.e., integrins) by modulating glyco gene expression may have therapeutic potential for the treat ment of malignant gliomas.
Methods
Cell Culture and Stable Transfection. Cells were maintained exactly as de scribed (5). The 1.3-kb protein coding region of the human ST6GalNAcV gene (UnigenelD: 181819), subcloned into the pcDNA3 expression vector, was transfected into human U373MG glioma cells, and G418-resistant transfectants screened for ST6GalNAcV expression by qRT-PCR.
Immunohistochemistry. Cell surface a2,6-linked sialoglycoconjugate expres sion was confirmed by using fluorescein isothiocyanate (FITC)-conjugated Sambucus nigra agglutinin (SNA) (Matreya) exactly as described (5) . SNA recognizes epitopes containing a2,6-linked sialic acid linked to either Gal or GalNAc (45) .
SNA Lectin Blot Analysis. Expression of cell-surface glycoproteins was evalu ated by SNA lectin blot analysis, as described (5), by using the DIG Glycan Differentiation Kit (Roche Molecular Biochemical), exactly as per the manufacturer's recommendations.
nLC-MS Detection of Polar Lipids. Polar lipids were extracted from cells and analyzed by nLC-MS as described (18, 19) and detailed in SI Methods. Data dependent MS/MS was performed in the linear quadrupole ion trap (CID) during collection of the ICR time-domain data. Mean fold change was cal culated by direct comparison of average ion signal magnitude in trans fectants vs. control cells, the combined data representing different ceramide chain compositions. To differentiate between Gb4/iGb4 isomers, EID exper iments were also performed as detailed in SI Methods.
Invasion Assay. In vitro invasivity was examined by using Biocoat Matrigel Invasion Chambers, exactly as described (5).
Cell Adhesion Assay. Cell adhesion to human fibronectin, laminin, and col lagen type I was measured, also as described (5).
Adhesion-Mediated Protein Tyrosine Phosphorylation. Cells were incubated on fibronectin-coated plates, unattached cells were removed, and Western blot analysis was performed by using a HRP-conjugated antiphosphotyrosine antibody (clone 4G10; Millipore) performed as described (5).
Phosphoproteomic Analysis. After adhesion to fibronectin as above, 300 pg of cell lysate protein was fractionated on an Agilent 3100 OFFGel Electropho resis Apparatus by using 24-cm IPG strips, pi 3-10 (GE Healthcare) in urea, thiourea, DTT, glycerol, and the corresponding GE ampholine under con ditions recommended by Agilent. The buffer in each well, containing fo cused proteins, was recovered for Western blot analyses to identify appropriate phosphoprotein-containing fractions by using an anti phosphotyrosine antibody. Protein identification in the corresponding band, excised from Coomassie-stained sister gels, was performed by nanoLC-MS/ MS of tryptic fragments, as described (46) 
